Universal Health Services price to free cash flow UHS
Market value divided by free cash flow over the last twelve months, since 2011.
- Today, Oct 23, 2026
- 13.0×
- 10-year median
- 16.4×
- Against its 10-year history
- 29th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 5.6× to 403×
- Peer median
- 22.6×
Universal Health Services' price to free cash flow is 13.0× as of Oct 23, 2026.
That is below its ten-year median of 16.4×, lower than on 71% of days in the last ten years.
Over that time it ranged from 5.6× in Jan 2021 to 403× in Apr 2022.
The median for 10 hospital and care facility stocks of a similar size is 22.6×.
Price to free cash flow over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 13.0× | 9.4× | 15.2× |
| 2025 | 14.7× | 9.5× | 16.2× |
| 2024 | 12.4× | 12.4× | 27.3× |
| 2023 | 25.3× | 16.8× | 79.9× |
| 2022 | 38.5× | 14.0× | 403× |
| 2021 | 63.8× | 5.6× | 77.0× |
| 2020 | 6.1× | 5.6× | 16.3× |
| 2019 | 15.9× | 14.9× | 20.3× |
| 2018 | 17.3× | 17.1× | 25.6× |
| 2017 | 20.5× | 12.9× | 22.2× |
| 2016 | 12.6× | 12.6× | 20.4× |
| 2015 | 14.9× | 14.3× | 19.9× |
| 2014 | 18.7× | 14.0× | 20.0× |
| 2013 | 15.4× | 12.3× | 17.7× |
| 2012 | 14.5× | 8.8× | 14.8× |
| 2011 | 9.2× | 8.1× | 17.2× |
Against its peers
Companies in Medical - Care Facilities nearest Universal Health Services' size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| UHSUniversal Health Services | 13.0× |
| DVADavita | 7.3× |
| ENSGEnsign | 24.4× |
| BTSGBrightSpring Health Services | 29.6× |
| EHCEncompass Health | 29.6× |
| PACSPACS | 16.6× |
| CHEChemed | 20.7× |
| THCTenet Healthcare | 7.2× |
| SHCSotera Health | 45.8× |
| CONConcentra Group Holdings Parent | 18.7× |
| LFSTLifeStance Health | 28.4× |
| Peer median | 22.6× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Universal Health Services
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.